CrushSCI.com
提供学术论文选刊润色服务
Cancer Medicine 期刊封面 医学
返回期刊列表

Review Cycle Records

Cancer Medicine

Wiley SCIE OA
2026新锐 3区2025中科院 3区2025 JCR Q2
233.8平均天数
218.5中位天数
54最短天数
567最长天数
9872025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

100 天

Spatial and Temporal Heterogeneity of Macrophage Efferocytosis in Tumors: Emerging Implications for Immunotherapy Biomarkers and Therapeutic Timing

作者Shanyi Li; Jilei Li; Zhenyu Zhang; Sizhe Wang; Chunzheng Ma

作者单位1. Henan University of Chinese Medicine Zhengzhou China; 2. Henan Provincial Hospital of Traditional Chinese Medicine Zhengzhou China

PDF源文件 DOI 网页
211 天

Cancer Patients Mortality From Other Causes: A European Population‐Based Study

作者Gemma Gatta; Riccardo Capocaccia; Silvia Rossi; Maria Athanasiadou; Damien Bennett; Ladislav Dusek; Jaume Galceran; Monica Hackl; Bernd Holleczek; Kaire Innos; Alexander Katalinic; Raphael Marcos‐Gragera; Deirdre Murray; Robin Schaffar; Stephanie Smits; Giedrė Smailytė; Hans Storm; Claudia Vener; Tina Žagar; Alice Bernasconi; Valerie Jooste; Laura Botta; the EUROCARE‐6 WG

作者单位1. Università Milano Bicocca Milan Italy; 2. Editorial Board Epidemiologia e Prevenzione Milan Italy; 3. Department of Oncology and Molecular Medicine Istituto Superiore di Sanità Rome Italy; 4. Cyprus Ministry of Health Nicosia Cyprus; 5. Northern Ireland Cancer Registry Queen's University Belfast Belfast UK; 6. Biostatistics and Analysis Institute Masarykova University Brno Czech Republic; 7. Epidemiology and Prevention Cancer Service Hospital Universitari Sant Joan de Reus, IISPV Reus Spain; 8. Austrian National Cancer Registry Wien Austria; 9. Saarland Cancer Registry Saarbrücken Germany; 10. National Institute for Health Development Tallin Estonia; 11. Institute of Social Medicine and Epidemiology University of Lubeck Lübeck Germany; 12. Girona Cancer Registry Catalan Institute of Oncology Girona Spain; 13. National Cancer Registry Ireland and Department of Public Health University College Cork Cork Ireland; 14. Geneva Cancer Registry, Institute of Global Health, Faculty of Medicine University of Geneva Geneva Switzerland; 15. Welsh Cancer Intelligence and Surveillance Unit Public Health Wales Cardiff UK; 16. Lithuania National CR, Institute of Oncology Vilnius University Vilnius Lithuania; 17. Danish Cancer Society Copenhagen Denmark; 18. Epidemiology and Prevention Unit Fondazione IRCCS Istituto Nazionale Dei Tumori Milan Italy; 19. Slovenian Cancer Registry Institute of Oncology Ljubljana Ljubljana Slovenia; 20. Digestive Cancer Registry of Burgundy Dijon Dijon France; 21. Centre Hospitalier Universitaire (CHU) Dijon Bourgogne Dijon France; 22. CTM Research Center—UMR1231, Institut National de la Santé et de la Recherche Médicale (INSERM) Dijon France; 23. Université Bourgogne Europe Dijon France

PDF源文件 DOI 网页
69 天

The Impact of Upfront DihydroPyrimidine Dehydrogenase ( DPD ) Testing on the Therapeutic Management of Patients Scheduled for 5‐ FU

作者Govind Kallee; Sébastien Salas; Gérard Milano; Florence Duffaud; Laetitia Dahan; Joseph Ciccolini

作者单位1. PRISM, Biogenopôle La Timone University Hospital of Marseille, APHM Marseille France; 2. COMPO, Inserm U1068, CRCM, Aix Marseille Univ, Institut Paoli Calmettes, INRIA Sophia Antipolis & Marseille Marseille France; 3. Medical Oncology La Timone University Hospital of Marseille, APHM Marseille France; 4. Scientific Direction, Centre Antoine Lacassagne Nice France; 5. Digestive Oncology La Timone University Hospital of Marseille, APHM Marseille France

PDF源文件 DOI 网页
567 天

Ethnic Differences in Unmet Care Needs Among Cancer Survivors in Utah Using a Mixed Methods Approach

作者Sara G. Jackson; Anne C. Kirchhoff; Sandra L. Edwards; Kimberly A. Herget; Marjorie E. Carter; Rachel R. Codden; Blessing S. Ofori‐Atta; Marie Nagata; Carol Sweeney; Morgan M. Millar

作者单位1. College of Nursing University of Utah Salt Lake City Utah USA; 2. Department of Pediatrics University of Utah School of Medicine Salt Lake City Utah USA; 3. Cancer Control and Population Sciences Program, Huntsman Cancer Institute University of Utah School of Medicine Salt Lake City Utah USA; 4. Utah Cancer Registry University of Utah School of Medicine Salt Lake City Utah USA; 5. Division of Epidemiology, Department of Internal Medicine University of Utah School of Medicine Salt Lake City Utah USA; 6. Utah Department of Health and Human Services Salt Lake City Utah USA

PDF源文件 DOI 网页
298 天

Phase Ib Trial of Finotonlimab Combined With SCT200 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

作者Jinguan Lin; Song Qu; Kunyu Yang; Tao Zhang; Yuansong Bai; Jian Wu; Yanjing Huang; Meiyu Fang; Xianling Liu; Xiaoming Huang; Nianyong Chen; Zhendong Li; Weidong Li; Songnan Zhang; Shurong Zhang; Guangyuan Hu; Yan Sun; Xiaohong Chen; Yanyan Liu; Shanghua Jing; Liangfang Shen; Zhiwei Chang; Liangzhi Xie; Wenlin Gai; Yan Wang; Xinyue Chen; Dongfang Liu; Ye Guo

作者单位1. The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital Changsha China; 2. Guangxi Medical University Cancer Hospital Nanning China; 3. Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China; 4. The First Affiliated Hospital of Chongqing Medical University Chongqing China; 5. The Third Bethune Hospital of Jilin University Changchun China; 6. Chongqing University Cancer Hospital Chongqing China; 7. Hainan General Hospital Haikou China; 8. Zhejiang Cancer Hospital Hangzhou China; 9. The Second Xiangya Hospital of Central South University Changsha China; 10. Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China; 11. West China Hospital Sichuan University Chengdu China; 12. Liaoning Cancer Hospital & Institute Shenyang China; 13. Affiliated Cancer Hospital and Institute of Guangzhou Medical University Guangzhou China; 14. Yanbian University Hospital Yanji China; 15. Beijing Tongren Hospital Affiliated to Capital Medical University Beijing China; 16. Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China; 17. Peking University Cancer Hospital Beijing China; 18. Henan Cancer Hospital Zhengzhou China; 19. The Fourth Hospital of Hebei Medical University Shijiazhuang China; 20. Xiangya Hospital of Central South University Changsha China; 21. The First Affiliated Hospital of Zhengzhou University Zhengzhou China; 22. Beijing Engineering Research Center of Protein and Antibody Sinocelltech Ltd. Beijing China; 23. Shanghai East Hospital, School of Medicine Tongji University Shanghai China

PDF源文件 DOI 网页
257 天

Construction and Validation of a Progression‐Free Survival Prediction Model for Newly Diagnosed Multiple Myeloma Patients With 1q21 Gain/Amplification

作者Yuexuan Rao; Shiyou Li; Aoyang Yu; Wenjie Yu; Zhiyuan Yao; Huanxin Zhang; Zhenyu Li

作者单位1. Department of Hematology Affiliated Hospital of Xuzhou Medical University Xuzhou Jiangsu Province China; 2. The First Clinical College of Xuzhou Medical University Xuzhou Jiangsu Province China

PDF源文件 DOI 网页
423 天

Telenursing to Improve Quality of Life in Women With Breast Cancer: A Systematic Review and Meta‐Analysis

作者Serena Ricchiuto; Diego Lopane; Stefano Mancin; Daniela Cattani; Alessandra Dacomi; Simone Cosmai; Mattia Bozzetti; Beatrice Mazzoleni

作者单位1. Humanitas University Milan Italy; 2. IRCCS Humanitas Research Hospital Milan Italy; 3. Department of Biomedical Sciences Humanitas University Milan Italy; 4. Direction of Health Professions, ASST Cremona Italy

PDF源文件 DOI 网页
137 天

Prognostic Value of Hemoglobin, Albumin, Lymphocyte, and Platelet Score in Locally Advanced Nasopharyngeal Carcinoma

作者JunMei Song; Lan Luo; Ting Liu; YuQing Lv; Qiulin Huang; Rensheng Wang; Jun Bie

作者单位1. Oncology Department Beijing Anzhen Nanchong Hospital, Capital Medical University (Nanchong Central Hospital) Nanchong Sichuan China; 2. The Second Clinical Medical College of North Sichuan Medical College Nanchong Sichuan China; 3. Department of Radiation Oncology The First Affiliated Hospital of Guangxi Medical University Nanning Guangxi China; 4. Oncology Department The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine (Xianhu District) Nanning Guangxi China; 5. Second Division of Department of Radiation Oncology Guangxi Academy of Medical, Sciences & The People's Hospital of Guangxi Zhuang Autonomous Region Nanning Guangxi China

PDF源文件 DOI 网页
226 天

Eosinophil Proportion May Serve as a Candidate Biomarker for Adverse Events in Patients With Urothelial Carcinoma Treated With Enfortumab Vedotin

作者Kunihiro Odagiri; Toshiharu Morikawa; Taku Naiki; Yosuke Sugiyama; Yoshihiko Tasaki; Yoshihisa Mimura; Aya Naiki‐Ito; Takashi Nagai; Toshiki Etani; Keitaro Iida; Daiki Ishikawa; Yusuke Noda; Nobuhiko Shimizu; Maria Aoki; Masakazu Gonda; Rika Banno; Hiroki Kubota; Ryosuke Ando; Yukihiro Umemoto; Noriyasu Kawai; Yoko Furukawa‐Hibi; Takahiro Yasui

作者单位1. Department of Clinical Pharmaceutics Nagoya City University Graduate School of Medical Sciences Nagoya Aichi Japan; 2. Department of Nephro‐urology Nagoya City University Graduate School of Medical Sciences Nagoya Aichi Japan; 3. Department of Urology Nagoya City University West Medical Center Nagoya Aichi Japan; 4. Department of Experimental Pathology and Tumor Biology Nagoya City University Graduate School of Medical Sciences Nagoya Aichi Japan; 5. Department of Urology Anjo Kosei Hospital Anjo Aichi Japan; 6. Department of Urology Konan Kosei Hospital Konan Aichi Japan; 7. Department of Urology Kainan Hospital Yatomi Aichi Japan

PDF源文件 DOI 网页
372 天

Effect of Tertiary Lymphoid Structures on Immune Cell Infiltration in the Tumor Microenvironment and Prognosis in Lung Adenocarcinoma

作者Sihong Le; Weidan Fang; Yitao Le; Ling Zhang

作者单位1. Department of Oncology The First Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang China; 2. Department of Urology The First Affiliated Hospital, Jiangxi Medical College, Nanchang University Nanchang China

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。